Spots Global Cancer Trial Database for food effect
Every month we try and update this database with for food effect cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546 | NCT04727138 | Oncology | EXS21546 Powder... EXS21546 Granul... Midazolam Food Effect Placebo Powder ... | 18 Years - 55 Years | Exscientia AI Limited | |
| Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients | NCT01902251 | Prostate Cancer Pharmacokinetic... | Enzalutamide ta... Enzalutamide ca... | 18 Years - | Astellas Pharma Inc | |
| Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib | NCT02040480 | Cancer | GSK2110183 Gela... GSK2110183 IR T... | 18 Years - 40 Years | GlaxoSmithKline | |
| A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants | NCT03649165 | Neurofibromatos... Healthy Partici... | Treatment A Treatment B Treatment C Treatment D Acetaminophen | 18 Years - 45 Years | AstraZeneca | |
| Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers | NCT01827644 | Cancer | Afuresertib GC ... Afuresertib HPM... Afuresertib ECT... Afuresertib GC ... Afuresertib HPM... Afuresertib ECT... | 18 Years - 40 Years | GlaxoSmithKline | |
| A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors | NCT04672460 | Advanced Solid ... Solid Tumors Ovarian Cancer Breast Cancer Prostate Cancer NSCLC Pancreatic Canc... Colorectal Canc... | TALZENNA capsul... Talazoparib sof... Talazoparib sof... | 18 Years - 70 Years | Pfizer | |
| 3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546 | NCT04727138 | Oncology | EXS21546 Powder... EXS21546 Granul... Midazolam Food Effect Placebo Powder ... | 18 Years - 55 Years | Exscientia AI Limited | |
| The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors | NCT04312282 | Advanced Solid ... | Tesetaxel Tesetaxel Itraconazole Rifampin | 18 Years - | Odonate Therapeutics, Inc. | |
| Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib | NCT02040480 | Cancer | GSK2110183 Gela... GSK2110183 IR T... | 18 Years - 40 Years | GlaxoSmithKline | |
| Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers | NCT01827644 | Cancer | Afuresertib GC ... Afuresertib HPM... Afuresertib ECT... Afuresertib GC ... Afuresertib HPM... Afuresertib ECT... | 18 Years - 40 Years | GlaxoSmithKline | |
| 3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546 | NCT04727138 | Oncology | EXS21546 Powder... EXS21546 Granul... Midazolam Food Effect Placebo Powder ... | 18 Years - 55 Years | Exscientia AI Limited | |
| Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib | NCT02040480 | Cancer | GSK2110183 Gela... GSK2110183 IR T... | 18 Years - 40 Years | GlaxoSmithKline |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
